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SUMMARY
The present work evaluated the diagnostic accuracy of detection of Dengue NS1 antigen employing two NS1 assays, an 
immunochromatographic assay and ELISA, in the diagnostic routine of Public Health laboratories. The results obtained with NS1 
assay were compared with virus isolation and, in a subpopulation of cases, they were compared with the IgM-ELISA results obtained 
with convalescent samples. A total of 2,321 sera samples were analyzed by one of two NS1 techniques from March to October 2009. 
The samples were divided into five groups: groups I, II and III included samples tested by NS1 and virus isolation, and groups IV 
and V included patients with a first sample tested by NS1 and a second sample tested by IgM-ELISA. Sensitivity, specificity, positive 
and negative predictive values, Kappa Index and Kappa Concordance were calculated. The results showed that NS1 testing in groups 
I, II and III had high sensitivity (98.0%, 99.5% and 99.3%), and predictive values and Kappa index between 0.9 - 1.0. Groups IV 
and V only had Kappa Concordance calculated, since the samples were analyzed according to the presence of NS1 antigen or IgM 
antibody. Concordance of 92.1% was observed when comparing the results of NS1-negative samples with IgM-ELISA. Based on the 
findings, it is possible to suggest that the tests for NS1 detection may be important tools for monitoring the introduction and spread 
of Dengue serotypes. 
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INTRODUCTION
The Dengue virus (DENV-1, DENV-2, DENV-3 and DENV-4) 
belongs to the Flavivirus genus of the Flaviviridae family. The genomic 
RNA is a single strand with approximately 11 kb in length and is 
composed of three structural protein genes that encode the nucleocapsid 
or core proteins (C), a membrane-associated protein (M), an envelope 
protein (E) and seven nonstructural protein genes: NS1, NS2a, NS2b, 
NS3, NS4a, NS4b and NS54.
Dengue fever has been clinically described in Brazil since the 19th 
century8, but laboratorial diagnosis was only introduced in 1981 in Boa 
Vista city, Roraima State in the Amazon region, when the serotypes 1 
and 4 were isolated23.
After 1981, only a few cases were reported, until 1986, when an 
outbreak caused by DENV-1 was confirmed in Rio de Janeiro, spreading 
to the other urban centers18. DENV-2 was introduced in 1990 and DENV-
3, in 200221,22. In 2010, the re-introduction of DENV-4 in Roraima State 
was confirmed. It subsequently spread to other states in the North19 
(states of Amazonas and Pará) and in the Northeast (states of Bahia, 
Pernambuco and Piauí)20.
In the Southeast, the first episode of the disease occurred in the Rio de 
Janeiro State in 201120. In the São Paulo State, the isolation of DENV-4 
was confirmed in February 2011 in patients residing in São José do Rio 
Preto and Paulo de Faria, two counties located in the northwestern region 
of the State (Rocco I.M., unpublished data).
Diagnostic methods currently available for the dengue virus infections 
are IgM antibody capture enzyme-linked immunosorbent assay (MAC-
ELISA), virus isolation in Aedes albopictus (C6/36) mosquito cells, and 
nested reverse transcription-polymerase chain reaction (Nested RT-PCR).
MAC-ELISA is the test of choice for rapid diagnosis in a single sample, 
collected after the 5th day of disease28. Serotype identification is obtained 
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after virus isolation in cell culture by indirect immunofluorescence assay 
(IFA) using type-specific monoclonal antibodies10.
The detection of the viral genome by RT-PCR, with specific primers 
for each serotype in clinical samples of the acute-phase of infection, can 
be performed by different protocols2,5,13. However, both virus isolation 
and RT-PCR procedures require sophisticated laboratories, skillful 
technicians, adherence to strict biosafety standards and good laboratory 
practices.
Recently, tests for detecting the Dengue NS1 antigen in human 
serum have been evaluated1,6,27,29. The NS1 antigen is found together 
with endothelium, free or soluble in the sera of patients, from one day 
before the onset of symptoms and can be detected at least up to five days 
after the onset of symptoms, allowing for an early diagnosis1,6,12,27,29. A 
previous study concluded that the test was more sensitive with samples 
collected up to day 3 after the onset of symptoms6.
There are two NS1 assay formats: immunochromatographic and 
ELISA. The immunochromatographic has the advantage of being faster 
and not requiring a sophisticated laboratory with expensive equipment6, 
while the ELISA assay takes longer and requires a better-equipped 
laboratory.
The present work aimed to evaluate the diagnostic accuracy for the 
detection of the Dengue NS1 antigen by two different assay formats: 
immunochromatographic and ELISA, when employed by Public Health 
laboratories. The results obtained with NS1 assays were compared with 
those obtained by the virus isolation technique, and also with those 
obtained in the second samples processed by IgM-ELISA.
MATERIALS AND METHODS
Sample collection: Serum samples were collected from March to 
October 2009 and sent for virus isolation at the Núcleo de Doenças de 
Transmissão Vetorial (NDTV) at the Instituto Adolfo Lutz, SP (IAL). 
These samples had been previously analyzed by NS1 assay at the 
Centro de Laboratórios Regionais (CLR) de São José do Rio Preto, in 
the counties of Ribeirão Preto and Presidente Prudente as well as at the 
Laboratório de Zoonoses e Doenças Transmitidas por Vetores from the 
Centro de Controle de Zoonoses of São Paulo (the capital city) (CCZ).
Serum samples collected up to the 3rd day after the onset of symptoms 
from patients clinically suspected of dengue infection, according to 
the definition of suspected cases28, were selected. The samples were 
collected in the acute phase of infection (days 1 to 3 after the onset of 
the symptoms). Day zero was considered the day of the onset of fever. 
Technicians from all network laboratories of IAL were trained to select 
samples and conduct tests for NS1 detection in both formats. Serum 
samples taken after the 3rd day and samples taken from dengue-suspected 
fatal cases were excluded.
The samples were processed as follows: 1) NS1-positive and NS1 
negative samples were submitted to virus isolation; 2) patients whose 
serum samples were NS1-negative were requested to have a 2nd blood 
sample collected from the 6th day after the onset of symptoms for IgM-
ELISA assay using commercial kits.
Evaluation of the technique of NS1 was made during the routine use 
of diagnostic kits, some samples were only processed by NS1 and these 
results were not confirmed by virus isolation or by IgM capture ELISA.
Although no specific protocol was established for this study, 
we analyzed the content of databases in order to obtain a broad and 
representative sample from the diagnostic routine of Public Health 
laboratories.
The test results analyzed in this study were obtained from the 
Information System and Hospital Management (SIGH). This database 
was implemented by, and is broadly used in the Instituto Adolfo Lutz’s 
laboratory network.
According to data extracted from SIGH and with the aim of 
conducting a performance analysis, samples were classified into five 
groups:
Group I: comprised 1,055 acute samples processed by NS1, 
with no information about which kit was used for NS1 detection 
(Immunochromatographic or ELISA) and using virus isolation as a 
reference technique.
Group II: comprised 266 acute samples, processed by NS1- 
immunochromatographic and using virus isolation as a reference 
technique.
Group III: comprised 362 acute samples, processed by NS1-ELISA 
and using virus isolation as a reference technique.
Group IV: comprised 747 acute samples processed by NS1- 
immunochromatographic and by IgM-ELISA commercial kits, performed 
on their respective convalescent samples.
Group V: comprised 519 samples processed by NS1-ELISA and by 
IgM-ELISA commercial kits, performed on their respective convalescent 
samples.
Detection of NS1 protein: we used the ELISA tests PlateliaTM 
Dengue NS1 Ag. Kit (Bio-Rad Laboratories, Marnes La Coquette, 
France) and Dengue Early ELISA PanBio (Inverness Medical Innovations 
Australia Pty Ltd /IMIA). The immunochromatographic assay used 
was the Dengue NS1 Ag. STRIP Kit (Bio-Rad Laboratories, Marnes La 
Coquette, France). The tests were performed according to manufacturer’s 
instructions.
IgM-ELISA commercial kit: Dengue IgM Capture ELISA Kit 
(Panbio Limited, Brisbane, Australia) was employed to analyze the 
convalescent samples, when the acute samples were NS1 non-reactive. 
The tests were performed following the manufacturer’s instructions.
Virus isolation: The viruses were isolated in tissue cultures. Twenty 
microliters of each serum sample were inoculated into tubes containing 
Aedes albopictus (C6/36) mosquito cells and incubated for nine days at 
28 °C in L-15 Leibovitz medium. After this period, the infection was 
detected by indirect immunofluorescence assays (IFA)10, using a pool 
of mice-immune ascitic fluid against the four Dengue serotypes3. The 
serotypes were identified by IFA using monoclonal antibodies10.
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NS1 tests were analyzed for sensitivity; specificity; positive 
predictive value (PPV); negative predictive value (NPV), with a 95% 
confidence interval (CI) for Groups I, II and III; probability (P) value 
between Groups II and III9,11,15; Kappa Index; and Concordance14. The 
samples with negative results in NS1 tests and virus isolation were used 
to analyze specificity.
For groups IV and V, only Kappa Concordance was calculated. 
Sensitivity, specificity, positive and negative predictive values were not 
calculated, since samples were different (acute or first and convalescent 
or second) and aimed at different diagnostic purposes (antigens or 
antibodies).
Ethical considerations: there were no conflicts of interest between 
the suppliers and producers of the kits and the Public Health Laboratories. 
We have analyzed only information retrieved from laboratory databases. 
All the samples included in the study were received by the laboratory for 
dengue diagnosis. The identities of the patients were kept confidential 
and biological samples were identified only by numbers.
RESULTS
A total of 2,321 samples were analyzed by one of two NS1 
techniques, and their results were compared to those obtained by virus 
isolation and IgM-ELISA.
Considering the 1,055 samples classified in Group I, which were 
analyzed by the NS1 test and using virus isolation as a reference, with 
no information in SIGH about which kit was used for NS1 detection, 790 
were NS1-positive and 726 of these were positive for virus isolation. The 
concordance between these two methodologies was 91.9%. Among the 
265 NS1-negative samples, there were 13 (4.9% of false NS1-negative) 
positive virus isolations (Table 1).
Among the 266 samples processed by NS1-immunochromatographic 
(Group II), 225 were NS1-positive. Out of a total of 362 samples 
processed by NS1-ELISA (Group III), 291 were NS1-positive. A 
concordance of 95.5% (Table 2) was observed when comparing the 
results obtained in the Groups II and III with the results of virus 
isolation.
Both formats of NS1 tests (ELISA and immunochromatographic) 
presented high sensitivity: 98.0% (95% CI: 97.2% - 99.1%) for Group 
I, 99.5% (95% CI: 98.6% - 100.0%) for Group II and 99.3% (95% CI: 
98.3% - 100.0%) for Group III. PPV and NPV were equally high. The 
differences in performance between groups II and III were not statistically 
significant (p > 0.05). The Kappa Index (Table 3) was evaluated as 
excellent (0.9 - 1.0)14.
The study protocol required that NS1-negative patients should return 
after the sixth day to collect a convalescent sample. Out of the 1,439 
NS1-negative patients only 1,174 (81.6%) returned. A concordance of 
92.1% was observed, comparing the results obtained with NS1-negative 
(immunochromatographic and ELISA) and the results obtained with 
IgM-ELISA.
Additionally, tests performed on the second blood samples collected 
Table 1
Results of NS1- immuochromatographic and NS1-ELISA compared to virus 
isolation (Group I)
NS1*
Virus isolation
Positive (%) Negative (%) Total (%)
Positive 726 (98.2)  64 (20.3) 790 (74.9)
Negative 13 (1.8) 252 (79.7) 265 (25.1)
Total 739 (100.0) 316 (100.0) 1055 (100.0)
* NS1: ELISA and immuochromatographic tests.
Table 2
Results of NS1 immunochromatographic test (Group II) and NS1 ELISA test (Group III) compared to virus isolation
Virus isolation
NS1 Group II Positive (%) Negative (%) Total NS1 Group III Positive (%) Negative (%) Total
Positive 215 (99.5) 10 (20.0) 225 (84.6) Positive 278 (99.3) 13 (15.9) 291 (80.4)
Negative 1 (0.5) 40 (80.0) 41 (15.4) Negative 2 (0.7) 69 (84.1) 71 (19.6)
Total 216 (100) 50 (100) 266 (100) Total 280 (100) 82 (100) 362 (100)
Table 3
Sensitivity, specificity, predictive values, confidence interval and Kappa index of Groups I, II and III
Groups Sensitivity 
(%), 95% CI*
Specificity 
(%), 95% CI
PPV* 
(%), 95% CI
NPV* 
(%), 95% CI
Kappa index
I 98.0, 97.2 - 99.1 80.0, 75.3 - 84.1 92.0, 90.0 - 93.8 95.0, 92.4 - 100.0 1.0
II 99.5, 98.6 - 100.0 80.0, 68.9 - 91.1 95.6, 92.9 - 98.2 97.6, 92.8 - 100.0 0.9
III 99.3, 98.3 - 100.0 84.1, 76.2 - 92.0 95.5, 93.2 - 97.9 97.2, 93.3 - 100.0 1.0
* 95% confidence interval; Positive Predictive Value (PPV); Negative Predictive Value (NPV)
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from 92 NS1-positive patients showed 98.9% agreement between NS1 
and IgM tests.
The most frequently isolated serotype observed was DENV-1 (538), 
followed by DENV-3 (173) and DENV-2 (28), with NS1 sensitivities of 
99.1%, 98.8% and 78.6% respectively (Table IV).
Concerning the analysis of DENV serotypes, it is important to point 
out that, NS1-positive samples from Groups II and III (516), are included 
in the total number of Group I samples. Only 516 out of 739 samples 
had information on which type of NS1 test was used.
DISCUSSION
Reported cases of dengue infection with hemorrhagic manifestations 
and other complications have become increasingly more frequent in 
tropical areas17.
Over the last few years, a shift in the age distribution of patients 
has been observed. Previously, dengue hemorrhagic fever (DHF) cases 
occurred mainly in adults, but currently there is a predominance of 
children under 15 years of age, especially in the northeastern region of 
Brazil where 65% of the total number of DHF cases were detected25. 
Furthermore, healthcare authorities should be prepared for the spread 
of DENV-4 since its re-introduction into Brazil in 201026.
There is an urgent need for a rapid, simple and sensitive laboratory 
assay, which would permit early clinical management of patients, 
preventing the malignant evolution of the disease, and would also allow 
for the rapid notification of public health authorities.
The NS1 tests can be used in hospitals as an important instrument 
to aid adequate support during a patient’s admission7, and the NS1 
immunochromatographic assay has also been shown to be efficient in 
airports for the detection of imported cases27.
The NS1 assay was used routinely by the public health laboratories 
of the São Paulo State from March to October 2009, and for the results 
analysis, the kit trademarks were not taken into consideration, only the 
format of the kits (ELISA or immunochromatographic).
 It is possible that the results obtained using the testing strategy outlined 
in this study will be different from results obtained from established dengue 
serum panels used to test new assays, due to the poorer quality of samples, 
such as lipemic or hemolyzed sera, with rheumatoid factor or unsuitable 
transport, storage and handling, all of which can affect assay results15.
The NS1 tests were performed at different laboratories and the 
samples were not analyzed for the presence of interfering factors such as 
lipids, rheumatoid factor and hemolysis. Consequently, the implication 
of these possible interfering factors could not be measured in this study.
Despite the different testing locations and conditions in this study, the 
results with samples collected up to the 3rd day indicate high sensitivity, 
specificity, PPV and NPV in NS1 immunochromatographic and NS1 
ELISA assays, when compared with virus isolation (Table 3).
The samples selected to analyze specificity were the ones that resulted 
negative in NS1 and virus isolation. Perhaps, due to this different purpose, 
the results for specificity were lower, in contrast with other studies6,16,24 
(Table 3). For Groups IV and V, only concordance was calculated. These 
groups comprised samples processed for IgM-ELISA, and these samples 
were not included to calculate specificity.
Comparing the results obtained by virus isolation and NS1 tests, a 
high concordance, both with NS1 immunochromatographic and NS1 
ELISA, was observed (95.5%). Although other authors have reported 
different sensitivities of NS1 tests for DENV-316, or DENV-2 and DENV-
417,24, it is noteworthy to mention that during the study period DENV-1 
and DENV-3 were the most commonly isolated serotypes - 72.8% and 
23.4% respectively.
Considering that the procedures were performed according to the strict 
rules of good laboratory practice and that the presence of the virus in the cell 
cultures is a definite visible fact, the probability of obtaining false-positive 
results in virus isolation is remote. In cases in which virus isolation results 
were negative and NS1 positive, it is necessary to consider at least two 
possibilities: the limitation of the test employed or that the false-negative 
results of virus isolation could be due to inadequate transportation and 
storage of the samples, which can lead to virus inactivation.
For those cases in which the acute samples were NS1 negative, the 
analysis of the results obtained by IgM-ELISA, with the convalescent 
samples, showed a concordance of 87.3% with NS1 ELISA and 95.1% 
with the NS1 immunochromatographic test.
Samples from two patients gave inconclusive results on testing with 
the NS1 immunochromatographic. One sample had an isolated virus and 
the other one did not. Therefore, it is recommended that NS1 inconclusive 
results be confirmed by virus isolation or by IgM-ELISA, with a second 
sample collected six days after the onset of symptoms.
The Kappa index for the groups I, II and III, showed excellent 
concordance and reliability (Table 3).
The introduction of NS1 as a tool for screening dengue positive 
Table 4
Dengue virus serotypes isolated from NS1 samples
Virus DENV-1 
Nº. (%)
DENV-2 
Nº. (%)
DENV-3 
Nº. (%)
Total 
Nº. (%)
NS1 - Positive 533 (99.1) 22 (78.6) 171 (98.8) 726 (98.2)
NS1 - Negative 5 (0.9) 6 (21.4) 2 (1.2) 13 (1.8)
Total 538 (100.0) 28 (100.0) 173 (100.0) 739 (100.0)
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samples led to an important increased success of virus isolation and 
also increased the number of counties in the São Paulo State that sent 
samples for virus isolation and the monitoring of new dengue serotypes 
(Fig. 1). Furthermore, this strategy can cut costs and reduce the number 
of samples that are processed by virus isolation.
It is very important to plan the introduction of a new methodology into 
the routine of dengue diagnostics, both in epidemic and inter-epidemic 
periods. In the study period, 1,439 samples were analyzed only by NS1 
detection. Of these, only 68 (4.7%) were positive, showing that lowering 
costs and labor by using positive NS1 to screening positive samples for 
isolation may not be worthwhile without a detailed surveillance plan.
Despite its costs, the analysis for the implementation of the NS1 
test for dengue fever in routine diagnoses in Public Health laboratories 
showed that the NS1 assay, when compared with virus isolation, is 
reliable. In conclusion, the NS1 assay is highly suitable for samples 
undergoing screening for virus isolation. In turn, the virus isolation will 
allow for the monitoring of the DENV-circulating serotypes.
It is important to consider that one methodology should not be 
employed exclusively to elucidate any given case, but must be used in 
parallel with other methodologies.
Further studies should focus on whether the NS1 assays are suitable 
for the diagnosis of fatal cases or patients with severe dengue, dengue 
hemorrhagic fever, and dengue shock syndrome.
RESUMO
Avaliação da detecção do antígeno NS1 para diagnóstico de 
dengue nos Laboratórios de Saúde Pública, Estado de São Paulo, 
2009
Esse estudo avaliou a acurácia do diagnóstico por detecção do 
antígeno NS1 do vírus Dengue empregando-se ensaios em dois formatos, 
imunocromatográfico e ELISA, na rotina diagnóstica dos laboratórios de 
Saúde Pública. Compararam-se os resultados de NS1 com os resultados 
de isolamento viral e, em parte dos casos, foi feita a comparação com 
os resultados de IgM-ELISA, obtidos nas segundas amostras. Um total 
de 2.321 amostras de soros, obtidas no período de março a outubro de 
2009, foram analisadas por uma das duas técnicas NS1. As amostras 
foram divididas em cinco grupos: I, II e III, que incluíram amostras 
analisadas por testes NS1 e por isolamento de vírus. Os grupos IV e 
V incluíram pacientes com a primeira amostra processada por NS1 e 
segunda por IgM-ELISA. Foram analisadas sensibilidade, especificidade, 
valor preditivo positivo e negativo, concordância e índice Kappa. 
Os resultados mostraram que os grupos I, II e III apresentaram alta 
sensibilidade (98,0%, 99,5% e 99,3%), valores preditivos e índice Kappa 
entre 0,9 - 1,0. Nos grupos IV e V, apenas concordância foi calculada, 
dado que as amostras foram analisadas quanto à presença de antígeno 
NS1 ou de anticorpos IgM. Comparando-se os resultados negativos de 
NS1 com IgM-ELISA houve 92,1% de concordância. Com base nas 
constatações feitas, é possível sugerir que a detecção de NS1 pode ser 
importante ferramenta para monitorar a introdução e disseminação dos 
sorotipos de Dengue.
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